Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
64.7M
-
Number of holders
-
157
-
Total 13F shares, excl. options
-
54.3M
-
Shares change
-
-4.06M
-
Total reported value, excl. options
-
$333M
-
Value change
-
-$49M
-
Put/Call ratio
-
3.08
-
Number of buys
-
78
-
Number of sells
-
-88
-
Price
-
$6.14
Significant Holders of Evolus, Inc. - Common Stock, par value $0.00001 per share (EOLS) as of Q3 2025
205 filings reported holding EOLS - Evolus, Inc. - Common Stock, par value $0.00001 per share as of Q3 2025.
Evolus, Inc. - Common Stock, par value $0.00001 per share (EOLS) has 157 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54.3M shares
of 64.7M outstanding shares and own 83.91% of the company stock.
Largest 10 shareholders include Nantahala Capital Management, LLC (5.73M shares), TANG CAPITAL MANAGEMENT LLC (5.49M shares), BlackRock, Inc. (4.48M shares), Caligan Partners LP (4.14M shares), VANGUARD GROUP INC (3.43M shares), Frazier Life Sciences Management, L.P. (2.63M shares), MILLENNIUM MANAGEMENT LLC (1.86M shares), Stonepine Capital Management, LLC (1.54M shares), STATE STREET CORP (1.52M shares), and Eversept Partners, LP (1.48M shares).
This table shows the top 157 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.